Innovation crisis at Big Pharma

The cost of research and development (R&D) for a new drug has been rising for years. As a new study by the Institute of Technology Management at the HSG (ITEM-HSG) shows, the average R&D costs per drug already amount to 6.1 billion dollars. In addition, another study shows that a large proportion of the drugs brought to market by the big pharmaceutical companies were not invented by them. In the video, Prof. Dr. Oliver Gassmann and Dr. Alexander Schuhmacher from ITEM-HSG explain the background to the innovation crisis in big pharma and what it could mean for the supply of medicines. 

Studies

• Analysis of pharma R&D productivitya new perspective needed
• Investigating the origins of recent pharmaceutical innovation